Results
110
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
110 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
URBN | US$36.91 | -6.0% | 16.0% | US$3.5b | US$41.35 | PE11x | E6.4% | n/a | ||
TLF | US$4.03 | -4.0% | -2.9% | US$35.0m | US$5.51 | PE14x | n/a | n/a | ||
ANF | US$136.81 | -3.5% | 87.9% | US$7.3b | US$186.00 | PE13.9x | E2.9% | 0% | ||
GRWG | US$1.78 | -4.8% | -33.6% | US$103.7m | US$3.42 | PS0.5x | E71.1% | n/a | ||
ULTA | US$343.26 | -10.3% | -16.2% | US$16.1b | US$397.00 | PE13.4x | E-0.8% | n/a | ||
RAY | US$1.64 | -4.9% | n/a | US$29.6m | n/a | PE22.6x | n/a | n/a | ||
WRBY | US$23.27 | 10.2% | 119.9% | US$2.8b | US$20.69 | PS3.8x | E125.7% | n/a | ||
CATO | US$6.08 | 3.1% | -10.3% | US$119.3m | n/a | PS0.2x | n/a | 11.2% | ||
TLYS | US$3.67 | -5.2% | -56.4% | US$111.0m | US$6.00 | PS0.2x | E81.4% | n/a | ||
BKE | US$47.22 | -3.2% | 24.3% | US$2.4b | US$46.00 | PE11.5x | E1.3% | 8.3% | ||
CAL | US$29.75 | -6.3% | 3.8% | US$1.0b | US$36.67 | PE6.7x | E2.1% | 0.9% | ||
ELA | US$6.50 | 5.7% | 63.3% | US$169.2m | US$8.00 | PE26.2x | E26.8% | n/a | ||
DIBS | US$3.80 | -5.4% | -11.7% | US$134.7m | US$8.00 | PS1.6x | E0.3% | n/a | ||
MYTE | US$7.23 | 15.5% | 143.4% | US$538.9m | US$5.66 | PS0.7x | E98.0% | n/a | ||
DTEA.F | US$0.26 | -0.7% | -29.1% | US$7.3m | n/a | PS0.2x | n/a | n/a | ||
SFIX | US$3.88 | 2.4% | 11.5% | US$472.0m | US$3.47 | PS0.4x | E35.5% | n/a | ||
GCT | US$23.26 | 7.6% | 145.4% | US$989.5m | US$53.37 | PE7.3x | E22.3% | n/a | ||
BBW | US$36.27 | -1.1% | 38.0% | US$485.3m | US$39.67 | PE9.6x | E3.8% | 2.2% | ||
MOGU | US$2.04 | -5.4% | 0.9% | US$17.3m | n/a | PS0.8x | n/a | n/a | ||
GLBE | US$47.86 | 13.3% | 51.9% | US$7.1b | US$46.08 | PS12.6x | E112.8% | n/a | ||
PETS | US$4.58 | -13.2% | -39.3% | US$93.5m | US$3.75 | PS0.4x | E-22.8% | 0% | ||
BGFV | US$1.63 | -8.4% | -71.0% | US$35.6m | n/a | PS0.04x | n/a | 0% | ||
DDS | US$419.12 | 7.9% | 23.3% | US$6.8b | US$332.33 | PE10.6x | E-31.4% | 5.0% | ||
SCVL | US$33.48 | -11.5% | 41.7% | US$914.9m | US$49.00 | PE11.8x | E7.9% | 1.6% |